Nahal R. Lalefar

Hematology | Oncology
747 52nd St
Oakland, CA 94609

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

High Predicted Thiotepa Exposure is Associated with Increased Risk of Thrombotic Microangiopathy and Non-Relapse Mortality in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation.

High Predicted Thiotepa Exposure is Associated with Increased Risk of Thrombotic Microangiopathy and Non-Relapse Mortality in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation.

Journal: Transplantation and cellular therapy
Published: June 09, 2026

Impact of Extramedullary Disease at Diagnosis on Outcomes Post Allogeneic Hematopoietic Cell Transplant in Children and Young Adults With Acute Myeloid Leukemia: A CIBMTR Report.

Impact of Extramedullary Disease at Diagnosis on Outcomes Post Allogeneic Hematopoietic Cell Transplant in Children and Young Adults With Acute Myeloid Leukemia: A CIBMTR Report.

Journal: Transplantation and cellular therapy
Published: November 06, 2025

Integrating pulmonary and systemic transcriptomes to characterize lung injury after pediatric hematopoietic stem cell transplant.

Integrating pulmonary and systemic transcriptomes to characterize lung injury after pediatric hematopoietic stem cell transplant.

Journal: JCI insight
Published: May 05, 2025

Integrating Pulmonary and Systemic Transcriptomic Profiles to Characterize Lung Injury after Pediatric Hematopoietic Stem Cell Transplant.

Integrating Pulmonary and Systemic Transcriptomic Profiles to Characterize Lung Injury after Pediatric Hematopoietic Stem Cell Transplant.

Journal: medRxiv : the preprint server for health sciences
Published: April 16, 2025

High Melphalan Exposure Increases the Risk of Graft-Versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation.

High Melphalan Exposure Increases the Risk of Graft-Versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation.

Journal: Transplantation and cellular therapy
Published: January 22, 2025

The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.

The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.

Journal: Transplantation and cellular therapy
Published: March 07, 2024

Effect of rabbit ATG PK on outcomes after TCR-αβ/CD19-depleted pediatric haploidentical HCT for hematologic malignancy.

Effect of rabbit ATG PK on outcomes after TCR-αβ/CD19-depleted pediatric haploidentical HCT for hematologic malignancy.

Journal: Blood advances
Published: January 16, 2024

Pulmonary microbiome and transcriptome signatures reveal distinct pathobiologic states associated with mortality in two cohorts of pediatric stem cell transplant patients.

Pulmonary microbiome and transcriptome signatures reveal distinct pathobiologic states associated with mortality in two cohorts of pediatric stem cell transplant patients.

Journal: medRxiv : the preprint server for health sciences
Published: December 11, 2023

Fertility Potential and Gonadal Function in Survivors of Reduced-Intensity Hematopoietic Stem Cell Transplantation.

Fertility Potential and Gonadal Function in Survivors of Reduced-Intensity Hematopoietic Stem Cell Transplantation.

Journal: Transplantation and cellular therapy
Published: December 04, 2023

Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.

Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.

Journal: Nature medicine
Published: November 29, 2023

Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.

Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.

Journal: Bone marrow transplantation
Published: August 07, 2023

Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.

Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.

Journal: Blood
Published: February 09, 2023
Showing 1-12 of 20

Last Updated: 09/26/2026